3,4-dihydroxybenzohydroxamic acid has been researched along with gentian violet in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, W; Fritzer-Szekeres, M; Hoechtl, T; Horvath, Z; Saiko, P; Szekeres, T; Tihan, T | 1 |
1 other study(ies) available for 3,4-dihydroxybenzohydroxamic acid and gentian violet
Article | Year |
---|---|
Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
Topics: Animals; Anti-Infective Agents, Local; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cell Line, Tumor; Chromatography, High Pressure Liquid; Coloring Agents; DNA Repair; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Gentian Violet; Glioblastoma; Glioma; Hydroxamic Acids; Oligonucleotide Array Sequence Analysis; Rats; Time Factors | 2004 |